QuantumCyte: Funding, Investors & Team (Sep 2026)
QuantumCyte is a company specialized in technology platforms, which has created a technique called 'in-situ lysis' to extract specific regions of interest (ROIs) from FFPE tissue slides. Our product is an automated system that utilizes digital tissue maps to precisely identify and isolate ROIs that consist of valuable biomarkers for aiding treatment decisions. This system is capable of conducting efficient and accurate tissue dissection, making it highly applicable in the fields of clinical diagnostics (precision medicine) and extensive biomarker research (biopharma).
QuantumCyte has raised $1.1M across 1 funding round on record, the most recent an undisclosed round of $1.1M announced in Aug 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
QuantumCyte Company Profile and Key Stats
Latest funding round on record: Aug 2023.
QuantumCyte Funding Rounds
QuantumCyte Founders and Leadership Team
Contact details for the QuantumCyte team: 1 of 1 has an email address on file.
Start 14-day free trial →QuantumCyte Funding Compared to Other Biotechnology Startups
QuantumCyte's latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like QuantumCyte in Biotechnology and Sunnyvale
Companies Similar to QuantumCyte
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
QuantumCyte Funding FAQs
What does QuantumCyte do?
QuantumCyte is a company specialized in technology platforms, which has created a technique called 'in-situ lysis' to extract specific regions of interest (ROIs) from FFPE tissue slides. Our product is an automated system that utilizes digital tissue maps to precisely identify and isolate ROIs that consist of valuable biomarkers for aiding treatment decisions. This system is capable of conducting efficient and accurate tissue dissection, making it highly applicable in the fields of clinical diagnostics (precision medicine) and extensive biomarker research (biopharma).
How much funding has QuantumCyte raised?
QuantumCyte has raised $1.1M across 1 round on record. The most recent is an undisclosed round of $1.1M announced in Aug 2023.
When did QuantumCyte last raise funding?
QuantumCyte's most recent funding round on record is an undisclosed round of $1.1M, announced in Aug 2023.
Who is the CEO of QuantumCyte?
John Butler is listed as CEO at QuantumCyte.
Where is QuantumCyte headquartered?
QuantumCyte is based in Sunnyvale, California, United States.
How many employees does QuantumCyte have?
QuantumCyte is in the 1-10 employee band.
How does QuantumCyte's funding compare to other Biotechnology startups?
QuantumCyte's latest round of $1.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's QuantumCyte Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for QuantumCyte is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.